Bracco Affirms ASNC Position Statement Elevating Cardiac PET with Myocardial Blood Flow as Preferred Standard for Coronary Artery Disease

Bracco, the market leader in diagnostic imaging and the pioneer in cardiac positron emission tomography (PET) for more than ...

Strata Acquires Ohio Valley Perfusion Associates

Strata Critical Medical, Inc. (Nasdaq: SRTA, "Strata" or the "Company"), today announced that it has completed the acquisition of Ohio Valley Perfusion Associates ("OVPA"), a regional provider of ...
Becker's Hospital Review

University Hospitals 1st in Ohio to adopt Flyrcado imaging agent

Cleveland-based University Hospitals Harrington Heart & Vascular Institute has become the first site in Ohio to clinically administer Flyrcado for the detection of coronary artery disease and arterial ...
Business Wire

ACC 2025: GE HealthCare announces the U.S. launch of pivotal innovations that will help transform the cardiology care pathway

The much-anticipated Flyrcado™ (flurpiridaz F 18) injection, a first-of-its-kind unit dose positron emission tomography myocardial perfusion imaging agent for the detection of coronary artery disease, ...
News Medical

Machine perfusion extends long-distance heart transplant possibilities

In places like Australia, where metropolitan areas are separated by an entire continent, donor hearts used to go unused simply because transplant teams couldn't get the organ to a recipient in time.

XVIVO Presents Encouraging Results From First Clinical Trial Using Hypothermic Oxygenated Perfusion (HOPE) In Direct Procurement DCD Heart Transplantation

GOTHENBURG, SE / ACCESS Newswire / April 22, 2026 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) - Today, the results ...